BPMC logo

Blueprint Medicines (BPMC) Cash From Operations

Annual CFO

-$192.59 M
+$244.26 M+55.91%

December 31, 2024


Summary


Performance

BPMC Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCcash flowmetrics:

Quarterly CFO

-$29.36 M
-$15.73 M-115.33%

December 31, 2024


Summary


Performance

BPMC Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCcash flowmetrics:

TTM CFO

-$192.59 M
+$49.56 M+20.47%

December 31, 2024


Summary


Performance

BPMC TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BPMC Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+55.9%+38.9%+42.2%
3 y3 years+35.5%+38.9%+42.2%
5 y5 years+30.7%+38.9%+42.2%

BPMC Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+61.7%-115.3%+77.9%at high+61.8%
5 y5-year-149.8%+61.7%-104.7%+77.9%-147.1%+61.8%
alltimeall time-149.8%+61.7%-104.7%+77.9%-147.1%+61.8%

Blueprint Medicines Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$192.59 M(-55.9%)
-$29.36 M(+115.3%)
-$192.59 M(-20.5%)
Sep 2024
-
-$13.64 M(-71.6%)
-$242.15 M(-27.3%)
Jun 2024
-
-$48.07 M(-52.6%)
-$333.00 M(-19.8%)
Mar 2024
-
-$101.51 M(+28.6%)
-$415.40 M(-4.9%)
Dec 2023
-$436.85 M(-13.0%)
-$78.93 M(-24.5%)
-$436.85 M(-8.9%)
Sep 2023
-
-$104.48 M(-19.9%)
-$479.32 M(-5.0%)
Jun 2023
-
-$130.47 M(+6.1%)
-$504.73 M(+2.5%)
Mar 2023
-
-$122.96 M(+1.3%)
-$492.51 M(-1.9%)
Dec 2022
-$502.28 M(+68.2%)
-$121.41 M(-6.5%)
-$502.28 M(+27.2%)
Sep 2022
-
-$129.89 M(+9.8%)
-$394.99 M(+9.5%)
Jun 2022
-
-$118.26 M(-10.9%)
-$360.69 M(+18.0%)
Mar 2022
-
-$132.73 M(+840.4%)
-$305.60 M(+2.3%)
Dec 2021
-$298.65 M(-177.2%)
-$14.11 M(-85.2%)
-$298.65 M(-3.5%)
Sep 2021
-
-$95.60 M(+51.3%)
-$309.34 M(-175.7%)
Jun 2021
-
-$63.16 M(-49.8%)
$408.58 M(+10.3%)
Mar 2021
-
-$125.78 M(+407.2%)
$370.58 M(-4.3%)
Dec 2020
$387.04 M(-239.2%)
-$24.80 M(-104.0%)
$387.04 M(+5.5%)
Sep 2020
-
$622.33 M(-715.2%)
$366.94 M(-212.2%)
Jun 2020
-
-$101.16 M(-7.5%)
-$327.09 M(+6.5%)
Mar 2020
-
-$109.33 M(+143.5%)
-$307.15 M(+10.5%)
Dec 2019
-$278.01 M
-$44.90 M(-37.4%)
-$278.01 M(-7.5%)
Sep 2019
-
-$71.70 M(-11.7%)
-$300.70 M(+5.9%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$81.23 M(+1.3%)
-$284.00 M(+38.1%)
Mar 2019
-
-$80.19 M(+18.7%)
-$205.63 M(+17.5%)
Dec 2018
-$175.01 M(+46.0%)
-$67.58 M(+22.9%)
-$175.01 M(+23.1%)
Sep 2018
-
-$55.01 M(+1823.9%)
-$142.18 M(+25.1%)
Jun 2018
-
-$2.86 M(-94.2%)
-$113.69 M(-17.8%)
Mar 2018
-
-$49.56 M(+42.6%)
-$138.35 M(+15.4%)
Dec 2017
-$119.86 M(+389.0%)
-$34.75 M(+31.0%)
-$119.86 M(+15.4%)
Sep 2017
-
-$26.52 M(-3.6%)
-$103.91 M(+8.2%)
Jun 2017
-
-$27.52 M(-11.5%)
-$96.03 M(+11.2%)
Mar 2017
-
-$31.08 M(+65.3%)
-$86.34 M(+252.2%)
Dec 2016
-$24.51 M(-22.6%)
-$18.80 M(+0.9%)
-$24.51 M(+30.7%)
Sep 2016
-
-$18.63 M(+4.5%)
-$18.76 M(+49.0%)
Jun 2016
-
-$17.83 M(-158.0%)
-$12.59 M(+116.6%)
Mar 2016
-
$30.75 M(-335.7%)
-$5.82 M(-81.6%)
Dec 2015
-$31.68 M(-10.5%)
-$13.05 M(+4.7%)
-$31.68 M(+4.9%)
Sep 2015
-
-$12.46 M(+12.8%)
-$30.21 M(+14.8%)
Jun 2015
-
-$11.05 M(-326.1%)
-$26.31 M(+10.1%)
Mar 2015
-
$4.89 M(-142.2%)
-$23.90 M(-32.5%)
Dec 2014
-$35.40 M(+86.1%)
-$11.58 M(+35.2%)
-$35.40 M(+48.6%)
Sep 2014
-
-$8.57 M(-0.9%)
-$23.82 M(+56.2%)
Jun 2014
-
-$8.64 M(+30.8%)
-$15.25 M(+130.8%)
Mar 2014
-
-$6.61 M
-$6.61 M
Dec 2013
-$19.02 M
-
-

FAQ

  • What is Blueprint Medicines annual cash flow from operations?
  • What is the all time high annual CFO for Blueprint Medicines?
  • What is Blueprint Medicines annual CFO year-on-year change?
  • What is Blueprint Medicines quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Blueprint Medicines?
  • What is Blueprint Medicines quarterly CFO year-on-year change?
  • What is Blueprint Medicines TTM cash flow from operations?
  • What is the all time high TTM CFO for Blueprint Medicines?
  • What is Blueprint Medicines TTM CFO year-on-year change?

What is Blueprint Medicines annual cash flow from operations?

The current annual CFO of BPMC is -$192.59 M

What is the all time high annual CFO for Blueprint Medicines?

Blueprint Medicines all-time high annual cash flow from operations is $387.04 M

What is Blueprint Medicines annual CFO year-on-year change?

Over the past year, BPMC annual cash flow from operations has changed by +$244.26 M (+55.91%)

What is Blueprint Medicines quarterly cash flow from operations?

The current quarterly CFO of BPMC is -$29.36 M

What is the all time high quarterly CFO for Blueprint Medicines?

Blueprint Medicines all-time high quarterly cash flow from operations is $622.33 M

What is Blueprint Medicines quarterly CFO year-on-year change?

Over the past year, BPMC quarterly cash flow from operations has changed by +$18.71 M (+38.92%)

What is Blueprint Medicines TTM cash flow from operations?

The current TTM CFO of BPMC is -$192.59 M

What is the all time high TTM CFO for Blueprint Medicines?

Blueprint Medicines all-time high TTM cash flow from operations is $408.58 M

What is Blueprint Medicines TTM CFO year-on-year change?

Over the past year, BPMC TTM cash flow from operations has changed by +$140.41 M (+42.17%)